Avances en Ataxia Telangiectasia
Este encuentro reúne a familiares de pacientes, investigadores y clínicos con el propósito de informar sobre los proyectos de investigación otorgados recientemente por la AEFAT. Además, también será un espacio…
Investigating Adaptive phenotypic plasticity as an early cancer evolutionary driver in paediatric solid cancers for improved treatment strategies
Speaker: Alejandra Bruna, PhD. Team Leader in Preclinical Modelling of Paediatric Cancer Evolution – Centre for Paediatric Oncology Experimental Medicine| Centre for Cancer Evolution: Molecular Pathology Division – The Institute of…
Organoides para estudiar y desarrollar nuevos tratamientos para la ataxia telangiectasia Notícias
Nuria Montserrat Pulido, investigadora principal del IBEC, con sede en el Parque Científico de Barcelona, liderará un proyecto para estudiar la Ataxia telangiectasia gracias a la financiación de la AEFAT,…
What can microfluidic technologies offer during self-assembly processes?
Josep Puigmartí-Luis, Departament de Ciència dels Materials i Química Física, Institut de Química Teòrica i Computacional (invited by César Rodriguez-Emmenegger). Self-assembly has long being used to control covalent and non-covalent…
12th CNAG symposium on genome research: the state-of-the-art genomic technologies
Genomics is an amazing new science. The complete genetic map of a species, or genome, is a source of extremely valuable information, with a wide variety of applications in important…
Immunotherapies using antibody engineering: new targets, strategies, and challenges
During the week, the 14th Annual Protein & Antibody Engineering Summit (PEGS) Europe will be held in Barcelona. Thus, that week the city will be gathering protein engineering and biotherapeutics experts in…
Vitala Technologies
VITALA TECHNOLOGIES es una empresa spin-off de l’IBEC que nace con la voluntad de revolucionar el campo de los análisis preclínicos de nuevos fármacos. Nuestra tecnología incluye el…
Immunotherapies using antibody engineering: new targets, strategies, and challenges
During the week, the 14th Annual Protein & Antibody Engineering Summit (PEGS) Europe will be held in Barcelona. Thus, that week the city will be gathering protein engineering and biotherapeutics experts in…
Strategies and approaches to optimize non-clinical development for cell and gene therapies
Barcelona Science Park and Labcorp organize an event to discuss strategies and approaches to optimize non-clinical development for cell and gene therapies with two main keynotes and a roundtable with a panel of…
Innovative FIH clinical trial design and Biomarker-driven Strategies to Help Accelerate Development of Your Oncology Therapeutic Program
Barcelona Science Park and Labcorp organize an event to talk about FIH clinical trial design and Biomarker driven strategies in oncology. We will discuss how using a novel early-phase clinical trial design and…
